
AAX Biotech, a Swedish biotechnology company specialising in next-generation antibody therapeutics, has launched a strategic partnership with Daiichi Sankyo, a …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

